People who received J&J vaccine may be better off with Moderna or Pfizer booster, study says
People who received a Johnson & Johnson coronavirus vaccine may be better off with a booster shot from Moderna or Pfizer, according to preliminary data...
FDA authorizes Pfizer booster shots for older and at-risk U.S. residents
Roughly 22 million Americans are at least six months past their second dose of the Pfizer vaccine, according to the Centers for Disease Control and...
Health officials advise White House to scale back booster plan for now
Top health officials have told the White House to scale back a plan to offer coronavirus booster shots to the general public this month, saying...
Heart problem more common after COVID-19 than after vaccination, study finds
The Pfizer-BioNTech COVID-19 vaccine is associated with an increased risk of myocarditis, a new study confirms. But the side effect remains rare, and COVID-19 is...
FDA expected to fully approve Pfizer vaccine next week
The Food and Drug Administration is pushing to approve Pfizer-BioNTech’s two-dose COVID-19 vaccine Monday, further expediting an earlier timeline for licensing the shot, according to...
As virus cases surge, Biden administration encourages more use of antibody treatments
Facing overcrowded hospitals and a surge of delta variant cases around the country, the Biden administration renewed its call for health providers to use monoclonal...
FDA to authorize third vaccine dose for people with weak immune systems
Federal regulators are expected to authorize a third shot of coronavirus vaccine as soon as Thursday for certain people with weakened immune systems, an effort...